MISSION, Kan., July 28, 2025 /PRNewswire/ -- (Family Features) From packing lunchboxes to after-school snacking and evening meals, school days can get hectic in the...
ICE! Headlines a Robust Lineup of Holiday Programming Across Each Destination
BETHESDA, Md., July 24, 2025 /PRNewswire/ -- The beloved Christmas tradition, ICE!, returns to six...
JUNO BEACH, Fla., July 21, 2025 /PRNewswire/ -- NextEra Energy Capital Holdings, Inc. today announced that it will conduct a remarketing of its Series M...
SAN FRANCESCO, July 18, 2025 /PRNewswire/ -- Elegoo, a rapidly developing brand in global smart manufacturing, joins Open Sauce today, one of the world's...
TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1 billion (USD 7.3...
Over 8,000 global entrepreneurs gather in Penang for five days of wellness innovation and mentorship.
HONG KONG, July 11, 2025 /PRNewswire/ -- QNET kicked off...
Autism eXchange is a Family- and Sensory-Friendly Conference That Can Also Be Enjoyed as a Staycation Weekend at Wilderness Resort
MILWAUKEE, July 9, 2025...
GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) to the Administration for Strategic Preparedness and Response (ASPR), part of the U. S. Department of Health and Human Services (HHS), for smallpox preparedness. ASPR exercised an option from its existing 10-year contract (75A50119C00037) for additional doses of VIGIV, a treatment for complications due to smallpox vaccination.
AAP, ACP, APHA, IDSA, MPHA, and SMFM Join Together to Stop Assault on Public Health
BOSTON, July 7, 2025 /PRNewswire/ -- Today, the American Academy...
MySmile's Independence Day sale offers 25% off all products from July 1st to 6th, making their viral water flossers, whitening kits, and sonic toothbrushes...